ADOCY Adocia SA Sponsored ADRs

Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: BioChaperone Lispro; BioChaperone Combo; HinsBet; BioChaperone Human Glucagon; BioChaperone Glargine GLP-1; and BioChaperone Prandaial Combinations for T1D. The company was founded by Gérard Soula, Olivier Soula and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$11.80    Pink
As of 03/23/2023     OTCMarkets

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  
IPO date:  05/22/2014
Outstanding shares:  8,563,955
Average volume:  0
Market cap:   $101,054,669
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy